B
bioAffinity Technologies, Inc. (BIAF)
NCM – Real Time Price. Currency in USD
1.88
-0.09 (-4.57%)
At close: May 12, 2026, 4:00 PM EDT
1.87
-0.01 (-0.60%)
Pre-market: May 13, 2026, 4:30 AM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
1.88
-0.09 (-4.57%)
At close: May 12, 2026, 4:00 PM EDT
1.87
-0.01 (-0.60%)
Pre-market: May 13, 2026, 4:30 AM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 2.60 | 2.46 | 10 | |
| Quick ratio | 2.58 | 2.06 | 10 | |
| Debt to Equity | 0.16 | -0.13 | 9.0 | |
| Debt to Assets | 0.11 | 1.87 | 9.0 | |
| Interest coverage | -240.03 | 4.31 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 5K | 3M | 9M | 6M | 6M |
| Gross Profit | -6K | 542K | 3M | 1M | 1M |
| Operating Income | -4M | -8M | -9M | -11M | -11M |
| Net Income | -8M | -8M | -9M | -15M | -15M |
| EBITDA | -4M | -8M | -8M | -10M | -10M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 33.99 | 58.82 | 10 |
| Next quarter | 31.74 | 55.7 | 10 |
| Current year | 18.58 | 6.47 | 7.0 |
| Next year | N/A | N/A | 1.0 |
| Weighted average score | 7.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 10.15 | 37.89 | 226.16 | -3.34 | 7.0 |
| Y/Y | -27.84 | -5.74 | 204.91 | -52.6 | 3.3 |
| 3y average | 17620.98 | -25.37 | 42.94 | -29.47 | 5.5 |
| 5y average | 10972.19 | -18.4 | 42.94 | -36.83 | 5.5 |
| Weighted average score | 5.3 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $6.4M significantly exceed its total debt $1.2M, ensuring strong financial flexibility
Total current assets $7.6M exceed Total current liabilities $2.9M, highlighting excellent liquidity
Debt-to-equity ratio (0.2) is well below the industry average (-0.1), showcasing prudent financial management
Interest coverage ratio (-240.0x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$2.6M limits the company's ability to reinvest or pay down debt